 
              The Board of Directors of Sanofi India Limited, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q3 CY2021), the company's total income was ₹ 769.2 crore, against ₹701.5 crore in the corresponding quarter of the previous year (YoY) and ₹806.2 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q3 CY2021), the company's net profit / (loss) was ₹529.8 crore, against ₹132.9 crore in the corresponding quarter of the previous year (YoY) and ₹178.3 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q3 CY2021), the company's Earnings Per Share (EPS) was ₹230.04, against ₹57.71 in the corresponding quarter of the previous year (YoY) and ₹77.42 in previous quarter (QoQ).
                            
       | Total Income | ₹ 769.2 crs | ₹806.2  crs |  -4.59% | ₹701.5 crs |  9.65% | 
      | Net Profit | ₹529.8 crs | ₹178.3  crs |  197.14% | ₹132.9 crs |  298.65 % | 
      | EPS | ₹230.04 | ₹77.42 |  197.13% | ₹57.71 |  298.61% | 
For the 9 Months period ended  September 30, 2021(9 Months Ended  CY 2021), the company's total income was ₹2326.8 crore, against ₹2255.2 crore in the previous year (YoY) (9 Months Ended  CY 2020).
The net profit / (loss) was at ₹854 crore for the 9 Months period ended  September 30, 2021 (9 Months Ended  CY 2021), compared to ₹354.6 crore in the previous year (YoY) (9 Months Ended  CY 2020).
The Earnings Per Share stood at ₹370.81 for the 9 Months period ended  September 30, 2021 (9 Months Ended  CY 2021), against ₹153.97 in the previous year (YoY) (9 Months Ended  CY 2020).
                    
      | Total Income | ₹2326.8 crs | ₹2255.2 crs |  3.17% | 
      | Net Profit | ₹854  crs | ₹354.6 crs |  140.83% | 
      | EPS | ₹370.81 | ₹153.97 |  140.83% | 
 
Shares of Sanofi India Limited was last trading in BSE at Rs. 8091.45 as compared to the previous close of Rs. 8275.85. The total number of shares traded during the day was 1493 in over 697 trades.
The stock hit an intraday high of Rs. 8300.00 and intraday low of 7999.00. The net turnover during the day was Rs. 12210286.00.
              
Source : Equity Bulls
              Keywords
                                       
                                               SanofiIndia 
                                               Q2FY22 
                                               H1FY22 
                                               ResultUpdate